Loading organizations...
Loading organizations...
Gene therapy company focused on neurodegenerative disease treatment.
NeuExcell Therapeutics has raised $24.5M across 2 funding rounds.
NeuExcell Therapeutics has raised $24.5M in total across 2 funding rounds.
NeuExcell Therapeutics has raised $24.5M in total across 2 funding rounds.
NeuExcell Therapeutics's investors include Jason Xinshan Kang, Huiju Xinxing, Huoshi Capital, Tao Shanshan, Suxin Yihe, Yijian Kexin, Xia Lei, Xin Huang, Foothill Ventures.
NeuExcell Therapeutics has raised $24.5M across 2 funding rounds. Most recently, it raised $14.5M Pre-Series A in May 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 4, 2023 | $14.5M Pre-Series A | Jason Xinshan Kang, Huiju Xinxing, Huoshi Capital, Tao Shanshan, Suxin Yihe, Yijian Kexin, Xia Lei | |
| Sep 1, 2021 | $10.0M Pre-Series A | Xin Huang | Foothill Ventures |